Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | UNK | — | OT |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | UNK | U8855BA | OT |
received two FLUZONE HD by mistake instead of getting one flu and one COVID vaccine with no reported adverse event; Initial information received on 22-Sep-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 83 years old female patient who received two Influenza Usp Trival A-B High Dose Subvirion Vaccine [Fluzone HD] by mistake instead of getting one flu and one Covid-19 Vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 21-Sep-2025, the patient received two doses of suspect Influenza Usp Trival A-B High Dose Subvirion Vaccine (lot U8855BA and expiry date-unknown) via unknown route in unknown administration site by mistake instead of getting one flu and one Covid-19 Vaccine with no reported adverse event (extra dose administered) (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.